BIIB vs CLX · P/E 21, rev $9.89B vs P/E 15, rev $7.10B
Biogen Inc (BIIB) versus The Clorox Company (CLX) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
The Clorox Company (CLX) is a household & personal products company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Not investment advice. Open the BIIB and CLX stock pages for the full models.
Not investment advice.